通用名藥物價格衰減
參考文件

↑  Applied Economics, 2004, 36, 731–73, The price premium of generic to brand-names and pharmaceutical price index, Ying Kon
↑  NHH Dept. of Economics Discussion Paper No. 39/2007, 6 July 2009, Regulation, generic competition and pharmaceutical prices: Theory and evidence from a natural experiment, Kurt R. Brekke, Tor Helge Holmas, Odd Rune Straume
↑  PDCI Report Series August 2002 Generic Drug Prices: A Canada US Comparison
↑  PDCI The 2004 Moffatt Prize in Economics, An Analysis on Waxman-Hatch Act: The Effect of Generic Entry on Pharmaceutical Prices, Tracy Chou
↑  NBER Working Paper No. 3803 (Also Reprint No. r1790), June 1993, Pricing, Patent Loss and the Market For Pharmaceuticals, Richard G. Frank, David S. Salkever
↑  Journal of Economics & Management Strategy, vol. 6, no. 1, pp. 75-90 Spring 1997, Generic Entry and the Pricing of Pharmaceuticals, Richard G. Frank, David S. Salkever
↑  JZMed, February 2010, The New Trend of API Sourcing and Contract Manufacturing in China, Jim J. Zhang, Ph.D.
↑  Journal of Generic Medicines Vol. 8, 1, 28–40, June 2011, The Role of authorized generics in the prescription drug marketplace, Natalia Shcherbakova, Marvin Shepherd, Kenneth Lawson & Kristin Richards
↑  SANTA CLARA COMPUTER & HIGH TECH. L.J. 489, 509, 2007 ,Do Reverse Payment Settlements Violate the Antitrust Laws?, Christopher M. Holman
↑  Generics Bulletin 8 Sept 2006 Guessing at prices means losing money
↑  Generics Bulletin 28 May 2010 Price falls are following a familiar pattern
1 2  Generics Bulletin 24 Nov 2006 Tracing prices before and after category M
↑  Generics Bulletin 17 Apr 2009 Does reimbursement affect price decay?
↑  U.S. Department of Commerce International Trade Administration, December 2004, Pharmaceutical Price Controls in OECD Countries
↑  PharmacoEconomics, Volume 28, Number 8, 1 August 2010 , pp. 649-663(15), Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review, Jaume  Puig-Junoy
↑  Inpharm, 15 October 2010, Government drops generic substitution plans
↑  Generics Bulletin, 22 Sept 2006, Ondansetron prices could decline by 60%
↑  Pharmaceutical Services Negotiating Committee (PSNC) Category M
↑  The NHS Business Services Authority (NHSBSA) publishes the English Drug Tariff online and in print each month
↑  Generics Bulletin, 19 Oct 2007, New tariff forces down pharmacy margins
1 2  Generics Bulletin, 23 Nov 2007, Taking the long view on pricing strategy
↑  URCH Publishing, 3 August 2009, Forecasting Generic Drug Prices Made Easy
↑  Generics Bulletin, 16 Feb 2007, Getting to the bottom of ‘bouncing’ price
↑  Generics Bulletin, 27 Apr 2007, Bounces may be extreme seasonal effects
↑  Generics Bulletin, 25 Sept 2009, Weak pound doesn’t mean higher prices
↑  Generics Bulletin, 20 March 2009, Tracking brand prices against generics
↑  International Journal of Medical Marketing Vol. 4, 1 65–73,  7 August 2003, Innovative marketing strategies after patent expiry: The case of GSK’s antibiotic Clamoxyl in France, Pierre Chandon
↑  BMJ, 27 June 2010, Generic substation could cost money unless reimbursement system is reformed, Martin G Duerden
↑  Managerial and Decision Economics, 28: 251–265, 17 AUG 2007 'Branded Generics’ as a strategy to limit cannibalization of pharmaceutical markets, David Reiffen and Michael R. Ward
↑  Harvard Healthcare Policy, 31 May 2011, The Value of Patent Expiration, Michael Chernew, PhD
↑  National Bureau of Economic Research, 15 Sept 2000, The long shadow of patent expiration, Generic entry and Rx to OCT switches, Berndt, Kyle & Ling
↑  . 國家教育研究院 雙語詞彙、學術名詞暨辭書資訊網. 2012 October  [26 October 2020].  请检查|date=中的日期值 (帮助)